Short-term and medium-term clinical outcomes of multisystem inflammatory syndrome in children: a prospective observational cohort study
Background Even though the incidence of Multisystem Inflammatory Syndrome in children (MIS-C) is decreasing cases are still reported across the world. Studying the consequences of MIS-C enhances our understanding of the disease’s prognosis. The objective of this study was to assess short- and medium-term clinical outcomes of MIS-C. Methods Prospective observational cohort study at Municipal Children’s Hospital Morozovskaya, Moscow, Russia. All children meeting the Royal College of Paediatrics and Child Health (RCPCH), Centers for Disease Control and Prevention (CDC), or the World Health Organization (WHO) MIS-C case definition admitted to the hospital between 17 May and 26 October 2020 were included in the study. All survivors were invited to attend a clinic at 2 and 6 weeks after hospital discharge. Results 37 children median age 6 years (interquartile range [IQR] 3.3–9.4), 59.5% (22/37) boys were included in the study. 48.6% (18/37) of patients required ICU care. One child died. All children had increased levels of systemic inflammatory markers during the acute event. Echocardiographic investigations identified abnormal findings in 35.1% (13/37) of children. 5.6% (2/36) of children were presenting with any symptoms six weeks after discharge. By six weeks the inflammatory markers were within the reference norms in all children. The echocardiographic evaluation showed persistent coronary dilatation in one child. Conclusions Despite the severity of their acute MIS-C, the majority of children in our cohort fully recovered with none having elevated laboratory markers of inflammation at 6 weeks, few (< 10%) reporting persistent symptoms at 6 weeks, and only one with persistent echocardiographic abnormalities..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:50 |
|---|---|
| Enthalten in: |
The Italian journal of pediatrics - 50(2024), 1 vom: 04. Jan. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Glazyrina, Anastasia [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
© The Author(s) 2023 |
|---|
| doi: |
10.1186/s13052-023-01569-7 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR054266831 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR054266831 | ||
| 003 | DE-627 | ||
| 005 | 20240105064734.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240105s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13052-023-01569-7 |2 doi | |
| 035 | |a (DE-627)SPR054266831 | ||
| 035 | |a (SPR)s13052-023-01569-7-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Glazyrina, Anastasia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Short-term and medium-term clinical outcomes of multisystem inflammatory syndrome in children: a prospective observational cohort study |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s) 2023 | ||
| 520 | |a Background Even though the incidence of Multisystem Inflammatory Syndrome in children (MIS-C) is decreasing cases are still reported across the world. Studying the consequences of MIS-C enhances our understanding of the disease’s prognosis. The objective of this study was to assess short- and medium-term clinical outcomes of MIS-C. Methods Prospective observational cohort study at Municipal Children’s Hospital Morozovskaya, Moscow, Russia. All children meeting the Royal College of Paediatrics and Child Health (RCPCH), Centers for Disease Control and Prevention (CDC), or the World Health Organization (WHO) MIS-C case definition admitted to the hospital between 17 May and 26 October 2020 were included in the study. All survivors were invited to attend a clinic at 2 and 6 weeks after hospital discharge. Results 37 children median age 6 years (interquartile range [IQR] 3.3–9.4), 59.5% (22/37) boys were included in the study. 48.6% (18/37) of patients required ICU care. One child died. All children had increased levels of systemic inflammatory markers during the acute event. Echocardiographic investigations identified abnormal findings in 35.1% (13/37) of children. 5.6% (2/36) of children were presenting with any symptoms six weeks after discharge. By six weeks the inflammatory markers were within the reference norms in all children. The echocardiographic evaluation showed persistent coronary dilatation in one child. Conclusions Despite the severity of their acute MIS-C, the majority of children in our cohort fully recovered with none having elevated laboratory markers of inflammation at 6 weeks, few (< 10%) reporting persistent symptoms at 6 weeks, and only one with persistent echocardiographic abnormalities. | ||
| 650 | 4 | |a Children |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a COVID-19 |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Multisystem inflammatory syndrome in children |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a MIS-C |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Paediatric inflammatory multisystem syndrome temporally associated with COVID-19 |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a PIMS-TS |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a SARS-CoV2 |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Sequelae |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Zholobova, Elena |4 aut | |
| 700 | 1 | |a Iakovleva, Ekaterina |4 aut | |
| 700 | 1 | |a Bobkova, Polina |4 aut | |
| 700 | 1 | |a Krasnaya, Ekaterina |4 aut | |
| 700 | 1 | |a Kovygina, Karina |4 aut | |
| 700 | 1 | |a Romanova, Olga |4 aut | |
| 700 | 1 | |a Blyuss, Oleg |4 aut | |
| 700 | 1 | |a Tutelman, Konstantin |4 aut | |
| 700 | 1 | |a Petrova, Polina |4 aut | |
| 700 | 1 | |a Bairashevskaia, Anastasiia |4 aut | |
| 700 | 1 | |a Rumyantsev, Mikhail |4 aut | |
| 700 | 1 | |a Korsunskiy, Anatoliy A. |4 aut | |
| 700 | 1 | |a Kondrikova, Elena |4 aut | |
| 700 | 1 | |a Nargizyan, Anzhelika |4 aut | |
| 700 | 1 | |a Yusupova, Valeriya |4 aut | |
| 700 | 1 | |a Korobyants, Evgeniya |4 aut | |
| 700 | 1 | |a Sologub, Anna |4 aut | |
| 700 | 1 | |a Kurbanova, Seda |4 aut | |
| 700 | 1 | |a Suvorov, Aleksandr |4 aut | |
| 700 | 1 | |a Sigfrid, Louise |4 aut | |
| 700 | 1 | |a Buonsenso, Danilo |4 aut | |
| 700 | 1 | |a Peroni, Diego G. |4 aut | |
| 700 | 1 | |a McArdle, Andrew James |4 aut | |
| 700 | 1 | |a Comberiati, Pasquale |0 (orcid)0000-0001-5209-9733 |4 aut | |
| 700 | 1 | |a Munblit, Daniel |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Italian journal of pediatrics |d London : BioMed Central, 2008 |g 50(2024), 1 vom: 04. Jan. |w (DE-627)SPR029703816 |w (DE-600)2084688-5 |x 1824-7288 |7 nnns |
| 773 | 1 | 8 | |g volume:50 |g year:2024 |g number:1 |g day:04 |g month:01 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1186/s13052-023-01569-7 |z kostenfrei |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 951 | |a AR | ||
| 952 | |d 50 |j 2024 |e 1 |b 04 |c 01 | ||